These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31417361)

  • 21. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease.
    Ostapchenko VG; Beraldo FH; Guimarães AL; Mishra S; Guzman M; Fan J; Martins VR; Prado VF; Prado MA
    J Neurochem; 2013 Nov; 127(3):415-25. PubMed ID: 23651058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes.
    Hamilton A; Zamponi GW; Ferguson SS
    Mol Brain; 2015 Mar; 8():18. PubMed ID: 25888324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.
    Nieznanska H; Bandyszewska M; Surewicz K; Zajkowski T; Surewicz WK; Nieznanski K
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2143-2153. PubMed ID: 29604335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.
    Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM
    Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
    Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin C in Alzheimer's disease.
    Kaur G; Levy E
    Front Mol Neurosci; 2012; 5():79. PubMed ID: 22783166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-beta oligomers increase the localization of prion protein at the cell surface.
    Caetano FA; Beraldo FH; Hajj GN; Guimaraes AL; Jürgensen S; Wasilewska-Sampaio AP; Hirata PH; Souza I; Machado CF; Wong DY; De Felice FG; Ferreira ST; Prado VF; Rylett RJ; Martins VR; Prado MA
    J Neurochem; 2011 May; 117(3):538-53. PubMed ID: 21352228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the cellular prion protein on amyloid-β and 3PO-tau processing.
    Schmitz M; Wulf K; Signore SC; Schulz-Schaeffer WJ; Kermer P; Bähr M; Wouters FS; Zafar S; Zerr I
    J Alzheimers Dis; 2014; 38(3):551-65. PubMed ID: 24028865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-molecule imaging reveals that small amyloid-β1-42 oligomers interact with the cellular prion protein (PrP(C)).
    Ganzinger KA; Narayan P; Qamar SS; Weimann L; Ranasinghe RT; Aguzzi A; Dobson CM; McColl J; St George-Hyslop P; Klenerman D
    Chembiochem; 2014 Nov; 15(17):2515-21. PubMed ID: 25294384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep inhibition induced by amyloid-β oligomers is mediated by the cellular prion protein.
    Del Gallo F; Bianchi S; Bertani I; Messa M; Colombo L; Balducci C; Salmona M; Imeri L; Chiesa R
    J Sleep Res; 2021 Jun; 30(3):e13187. PubMed ID: 32902030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
    Scialò C; Legname G
    Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.